Selenium (Se) is an essential micronutrient and is circulated to the food chain through crops. Brassica species are efficient in Se accumulation and thus, good species for Se biofortification purposes. The residual fraction obtained after oil processing of Brassica seeds, the meal, is an important protein source in animal diets and used in feed concentrates. The accumulation of soil or foliar applied Se in the seeds and meal of Brassica napus and B. rapa as well as its effects on growth and yield formation was studied in two field experiments. Also, a HPLC-ICP-MS based method for the identification and quantification of Se species in Brassica seeds and meal was developed. Selenium application did not affect the yield or oil content. High accumulation of Se in the seeds and meal (1.92-1.96 μg Se g −1 ) was detected. Biotransformation of inorganic Se was evaluated by using HPLC-ICP-MS previous enzymatic hydrolysis for species extraction. The Se speciation studies showed that up to 85% of the total Se was SeMet whereas other Se-species were not detected. We conclude that the agronomic biofortification of Brassica species can improve the nutritive quality of the protein rich meal fraction as it contains significant amount of SeMet.

Selenium is an essential element for human health. The benefits of selenium are many including protection against cancer, heart diseases and other cardiovascular and muscle disorders. Selenium is also helpful in controlling gastrointestinal disorders, enhancing immunity of the human body and reducing age-related diseases. The health-promoting properties of Se are due to vital functions of selenoproteins in which selenium is present as selenocysteine, the 21st amino acid. To date, dozens of selenoprotein families have been described though many have roles that have not been fully elucidated. Selenoproteins research has attracted tremendous interest from different scientific areas. Analytical chemists have not remained indifferent to the attractive features of these unique proteins. Different analytical techniques, such as multidimensional chromatography-inductively coupled plasma mass spectrometry (ICPMS), electrospray (tandem) mass spectrometry (ESI-MS/MS), matrix-assisted laser desorption ionization time-of flight (MALDI-TOF) and sodium dodecyl sulphate polyacrylamide gel electrophoresis-laser ablation inductively coupled plasma mass spectrometry (SDS-PAGE-LA-ICPMS), have been applied to the determination of selenoproteins and selenium-containing proteins. This review describes the best-characterized selenoproteins to date in addition to the major contributions of analytical chemistry to the field of selenoproteins. The article also highlights the challenges of combining elemental and molecular mass spectrometry for the determination of selenoproteins and selenium-containing proteins.

The increasing use of metallic nanoparticles (MNPs) in a wide variety of applications have consequently lead to an urgent need to evaluate the impact of these new materials on human health and the environment. To date, the potential toxicity of MNPs as well as their interaction mechanisms with cells and living organisms have not been fully addressed. In this article, we discuss the different bioanalytical strategies that have been used so far with this purpose. We consider different methods aim to evaluate cellular uptake and localization in cells and tissues, and in vitro methods for the study of the toxicity induced by MNPs considering different toxicity markers and high throughput approaches for the identification of specific targets involved in the cell-MNPs interaction. Special strategies related to the use of animal models to assess in-vivo toxicity of MNPs are also discussed.

Selenium nanoparticles have been recently proposed as a potential chemotherapeutic agent due to its low toxicity and its ability to arrest the cell cycle of cancer cells. However, the biochemical mechanisms associated to this effect have not yet been uncovered. We evaluate here the potential of chitosan-stabilized selenium nanoparticles to induce cell cycle arrest and to inhibit in-vitro invasiveness in HepG2 cells. In addition, we use a quantitative proteomic approach to identify potential protein targets involved in the mechanisms associated to selenium nanoparticles exposure. Our data suggest that the induction of the cell cycle arrest at the S phase is mediated by de-regulation of the eIF3 protein complex. We found additional de-regulated proteins upon selenium nanoparticles exposure that could also be involved in the overall inhibition of cell proliferation. These findings not only support the potential of chitosan-stabilized selenium nanoparticles as anti-cancer therapy but also provide a deeper insight into the mechanisms associated to their chemotherapeutic effects.

The essential micronutrient selenium (Se) is retained better in animal and human tissues in its organic forms while nonprotein selenoamino acids, such as selenomethylselenocysteine (SeMetSeCys), are considered as functional organic Se species. We studied the ability of oilseed rape Brassica napus to metabolize inorganic selenate/selenite (SeVI/SeIV) into various organic Se species, including SeMetSeCys. At 14 d after the inorganic Se application, 33% of the Se had accumulated as selenomethionine (SeMet) and 60% as SeVI, whereas no SeMetSeCys was detected. SeMet was the main organic Se species (53−94%) in seeds. Brassica napus selenocysteine methyltransferase (SMT) protein sequence revealed a substitution typical of nonaccumulators explaining the low SeMetSeCys accumulation. Brassica napus absorbs rapidly inorganic Se and converts it into organic Se forms, mainly SeMet, that are suitable for augmenting animal feed and thereby supplementing the human food chain in Se-deficient countries. In contrast, Se biofortification did not result in accumulation of the more valuable SeMetSeCys.